Thrombosis management

APRIL 17, 2019

[Emergency department discharge of pulmonary embolus patients ]

PEACOCK WF, COLEMAN CI, DIERCKS DB, FRANCIS S, KABRHEL C, KEAY C, KLINE JA, MANTEUFFEL J, WILDGOOSE P, XIANG J, SINGER AJ.

[ ]

HUN

Thrombosis management

APRIL 17, 2019

[Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis]

VEDOVATI MC, GIUSTOZZI M, BONITTA G, AGNELLI G, BECATTINI C.

[ ]

HUN

Thrombosis management

APRIL 17, 2019

[Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH]

KHORANA AA, NOBLE S, LEE AYY, SOFF G, MEYER G, O’CONNELL C, CARRIER M.

[ ]

HUN

Thrombosis management

APRIL 17, 2019

[Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF]

CHEN ST, HELLKAMP AS, BECKER RC, BERKOWITZ SD, BREITHARDT G, FOX KAA, HACKE W, HALPERIN JL, HANKEY GJ, MAHAFFEY KW, NESSEL CC, PICCINI JP, SINGER DE, PATEL MR.

[ ]

HUN

Thrombosis management

APRIL 17, 2019

[Rivaroxaban with or without aspirin in stable cardiovascular disease ]

EIKELBOOM JW, CONNOLLY SJ, BOSCH J, DAGENAIS GR, HART RG, SHESTAKOVSKA O, DIAZ R, ALINGS M, LONN EM, ANAND SS, WIDIMSKY P, HORI M, AVEZUM A, PIEGAS LS, BRANCH KRH, PROBSTFIELD J, BHATT DL, ZHU J, LIANG Y, MAGGIONI AP, LOPEZ-JARAMILLO P, O’DONNELL M

[ ]

HUN

Thrombosis management

APRIL 17, 2019

[Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data ]

DI Lullo L, TRIPEPI G, RONCO C, DE Pascalis A, BARBERA V, GRANATA A, RUSSO D, DI Iorio BR, PAOLETTI E, RAVERA M, FUSARO M, BELLASI A.

[ ]

HUN

Thrombosis management

APRIL 17, 2019

[Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) nonvitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patients]

MCHORNEY CA, PETERSON ED, ASHTON V, LALIBERTÉ F, CRIVERA C, GERMAIN G, SHEIKH N, SCHEIN J, LEFEBVRE P.

[ ]

HUN

Thrombosis management

APRIL 17, 2019

[Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS ]

CAMM AJ, AMARENCO P, HAAS S, HESS S, KIRCHHOF P, LAMBELET M, BACH M, TURPIE AGG XANTUS Investigators

[ ]

HUN